Business
Currency:USD
2024/H1
Stock NameRevenueRatio
Cell therapy280.32M49.93%
生命科学服务及产品217.72M38.78%
Biological preparation development service37.13M6.61%
Industrial synthetic biological products26.11M4.65%
经营管理分部88K0.02%
Product
No Data
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States of America505.95M60.27%
The mainland of China162.54M19.36%
Europe99.52M11.85%
亚太地区(不包括中国内地)53.23M6.34%
Other18.28M2.18%